{"id":"W4411453748","doi":"10.1080/14796694.2025.2513219","title":"Plain language summary of the ECHELON-3 study: brentuximab vedotin combination treatment in people with diffuse large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"BeiGene; Sanofi; AstraZeneca; Pfizer","keywords":"Brentuximab vedotin; Medicine; Oncology; Internal medicine; Lymphoma; Diffuse large B-cell lymphoma; Medical physics; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006687024,0.0009469232,0.003181736,0.001136036,0.0004842807,0.00296308,0.00142001,0.002366068,0.05628146],"category_scores_gemma":[0.02442794,0.0006197492,0.003147605,0.001813809,0.0003974625,0.001585325,0.0006352597,0.003113557,0.00986992],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001299572,"about_ca_system_score_gemma":0.001870091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002734299,"about_ca_topic_score_gemma":0.003301379,"domain_scores_codex":[0.9944291,0.003161024,0.001140862,0.0002548519,0.0008295546,0.0001846153],"domain_scores_gemma":[0.9821081,0.009090735,0.003955599,0.0003641916,0.003544042,0.0009375151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02131829,0.0002370148,0.002594302,0.02764806,0.002214192,0.0001872015,0.0001032178,0.0002047412,0.0004282955,0.0005138885,0.8672499,0.07730102],"study_design_scores_gemma":[0.1068881,0.01025937,0.0356219,0.0466855,0.01028282,0.000790335,0.0004249466,0.0004239846,0.0008235035,0.002098113,0.7853541,0.0003473432],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.01830987,0.4186452,0.002549548,0.1950229,0.05936707,0.006720573,0.214922,0.0005916866,0.08387119],"genre_scores_gemma":[0.1119808,0.2870117,0.0052278,0.3530846,0.05960322,0.01676914,0.09233983,0.0006528904,0.07332997],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.05628146,"threshold_uncertainty_score":0.1882802,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004727756126626704,"score_gpt":0.2676412565808298,"score_spread":0.2629135004542031,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}